TP53 and lung cancer: Tang et al. [160] utilized G0-C14 cationic lipids, mRNA hyaluronic acid, and DSPE-PEG-mannose to develop inhaled, dual-targeted mRNA nanoparticles, successfully targeted to deliver p53 mRNA to lung cancer cells and inflammatory macrophages within the lung.